| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 18.323 | 17.798 | 21.195 | 25.616 | 29.943 | 29.273 | 29.347 | 49.214 | 51.121 | 22.238 |
| Total Income - EUR | 25.644 | 25.982 | 30.438 | 35.105 | 39.565 | 38.861 | 30.506 | 54.742 | 61.489 | 40.709 |
| Total Expenses - EUR | 38.721 | 37.534 | 41.741 | 25.491 | 26.648 | 32.841 | 30.150 | 45.791 | 60.007 | 47.973 |
| Gross Profit/Loss - EUR | -13.077 | -11.551 | -11.303 | 9.613 | 12.917 | 6.020 | 356 | 8.950 | 1.482 | -7.264 |
| Net Profit/Loss - EUR | -13.453 | -12.342 | -12.771 | 8.584 | 11.709 | 4.916 | -559 | 7.308 | 959 | -7.264 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Eutrofic Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 26.979 | 7.785 | 6.258 | 5.615 | 8.716 | 8.668 | 8.895 | 6.517 | 5.078 | 5.105 |
| Current Assets | 18.447 | 15.111 | 6.657 | 21.258 | 13.448 | 13.611 | 9.418 | 22.212 | 25.835 | 19.697 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 7.301 | 4.795 | 5.433 | 7.862 | 7.437 | 7.644 | 1.058 | 11.319 | 10.685 | 3.018 |
| Cash | 11.147 | 10.316 | 1.223 | 13.396 | 6.011 | 5.967 | 8.359 | 10.893 | 15.150 | 16.679 |
| Shareholders Funds | 15.345 | 2.847 | -9.973 | -1.206 | 10.526 | 15.242 | 14.345 | 21.698 | 22.471 | 15.081 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 30.081 | 20.048 | 22.887 | 28.079 | 11.638 | 7.037 | 3.967 | 6.581 | 8.442 | 9.721 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 450 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Eutrofic Med Srl